RUNX2 and osteoporosis: Overexpression of FTO in BMSC promoted the progression of osteoporosis by inhibiting osteogenic differentiation through demethylation of Runx2 gene, and inhibition of FTO in ovariectomized mice showed increased bone formation, partially alleviating OVX-induced osteoporosis.